11-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Extracorporeal Membrane Oxygenation Market by Modality (venoarterial (VA), Venovenous (VV) and Arteriovenous (AV)), Application (Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR)): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Extracorporeal Membrane Oxygenation market in 2019 was approximately USD 285.45 million. The market is expected to grow at a CAGR of 4.40% and is anticipated to reach around USD 384.71 million by 2026.
Extracorporeal membrane oxygenation (ECMO), commonly known as extracorporeal life-support (ECLS), is an extracorporeal treatment that delivers continuous cardiovascular and respiratory support to patients whose heart and lungs cannot provide sufficient lifelong exchange.ECMO's procedure derives mainly from cardiopulmonary bypass that provides short-term assistance for suspended native circulation. The ECMO system substitutes for heart and lung role.
Browse the full “Extracorporeal Membrane Oxygenation Market by Modality (Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV)), Application (Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR)): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/extracorporeal-membrane-oxygenation-market-by-modality-venoarterial-va-693
A growing incidence of chronic obstructive pulmonary disorder (COPD), cardiopulmonary disease, and respiratory failure around the globe will provide considerable potential for growth in timeline forecasts of extracorporeal membrane oxygenation on the world market. According to the World Health Organization, chronic obstructive pulmonary disease (COPD) affects around 65 million individuals annually, and the illness triggers about 3 million deaths globally each year. Approximately 17.9 million people died in 2016 as a result of cardiovascular disease (CVD), representing approximately 31 percent of total deaths worldwide. Rising prevalence of unhealthy habits and smoking tobacco would lead to increased occurrence of respiratory disorders which will fuel market growth over the expected period of time.
The market for Extracorporeal Membrane Oxygenation divided into modality, application, and region. The disorder type segment is classified into Venovenous (VV), Arteriovenous (AV) and Venoarterial (VA). The Venovenous (VV) product is projected to have the highest market share in 2019. The large proportion of this group is attributed mostly to the high incidence of respiratory failure, rising lung transplants, and technological advances. The Arteriovenous category (AV) is expected to grow at the highest CAGR in the forecast period. The application segment is classified into extracorporeal cardiopulmonary resuscitation (ECPR), respiratory diseases and cardiac diseases. The cancer group accounted for the biggest market share in 2019. The large proportion of this segment may be due to the increased occurrence of cancer-related lymphedema, and increased awareness of early disease detection.
Geographically the market is segmented into the regions that comprise the current and forecast market demand for the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa with its further split into major countries.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 285.45 Million |
Projected Market Size in 2026 |
USD 384.71 Million |
CAGR Growth Rate |
4.40% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
ALung Technologies, Inc, EUROSETS S.r.l, Getinge Group, LivaNova PLC, Medtronic plc, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., Terumo Corporation, and others. |
Key Segment |
By, Modality, Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the players included in Extracorporeal Membrane Oxygenation are ALung Technologies, Inc, EUROSETS S.r.l, Getinge Group, LivaNova PLC, Medtronic plc, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., Terumo Corporation, XENIOS AG amongst others.
This report segments the Extracorporeal Membrane Oxygenation Market as follows:
Global Extracorporeal Membrane Oxygenation Market: Modality Segment Analysis
- Venoarterial (VA)
- Venovenous (VV)
- Arteriovenous (AV)
Global Extracorporeal Membrane Oxygenation Market: Application Segment Analysis
- Respiratory diseases
- Cardiac diseases
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Global Extracorporeal Membrane Oxygenation Market: Regional Segment Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
